Leadership Team

management Team

Bruce J. Shook

President and CEO

Peter A. Schneider, MD

Chief Medical Officer

Joseph C. Griffin, III

Vice President of Regulatory Affairs and Quality Assurance,
Compliance Officer

Howard Rosen

Vice President of Marketing and Business Development

Mike Longo

Vice President of Research and Development

Marc Penna

Vice President of Clinical Affairs

Monica L. Klos

Controller

Board of Directors

Mark Garcia, MD

Co-founder & Medical Director 
Vascular & Interventional Associates of Delaware

Neil Hattangadi, MD

CEO, Cortica
Former Business Leader, Peripheral Vascular, Philips

Justin Klein, MD, JD

Partner, New Enterprise Associates

P. Sherrill Neff

Partner, Quaker Partners

Peter A. Schneider, MD

Chief Medical Officer, Vesper Medical
Vascular Surgeon, Kaiser Permanente Moanalua Center, Honolulu

Dennis Wahr, MD

President & CEO of Nuvaira, Inc.
Former CEO, Lutonix, Inc. 

Scientific Advisory Board

Peter Neglen, MD

Retired

Paul Gagne, MD

Southern Connecticut Vascular Center, Darien, CT

Stephen Black, MD

Guy’s and St. Thomas’ NHS Foundation Trust, London, UK

Rick de Graaf, MD

Maastricht U., Maastricht, NL

Michael Lichtenberg, MD

Klinikum Arnsberg, Arnsberg, Germany

Gerry O’Sullivan, MD

Galway U., Galway, Ireland

Thomas Zeller, MD

Universitaet-Herzzentrum, Bad Krozingen, Germany

Marianne Brodmann, MD

Medical U. Graz, Graz, Austria

Mike Dake, MD

Stanford U., Stanford, CA

Mahmood Razavi, MD

Vascular & Interventional Specialists of Orange County, Orange, CA 

Raghu Kolluri, MD

Ohio Health Heart and Vascular, Columbus, OH

Deepak Sudheendra, MD

University of Pennsylvania, Philadelphia, PA

ERIN MURPHY, MD

Sanger Heart & Vascular Institute, Charlotte, NC

Patty Thorpe, MD

Arizona Heart Hospital, Phoenix, AZ

John Rundback, MD

Holy Name Medical Center, Teaneck, NJ

Kathleen Gibson, MD

Lake Washington Vascular, Bellevue, WA

Investors

Vesper Medical is backed by New Enterprise Associates (NEA) and Quaker Partners.

NEA
quacker